Table 2 Survival statistics of patients with surgery and in different breast cancer subtypes.

From: Neoadjuvant Chemotherapy Creates Surgery Opportunities For Inoperable Locally Advanced Breast Cancer

Subtypes>1 year (n = 49)>3 years (n = 29)>5 years (n = 8)
Survival without LR45(91.8%)13(44.8%)1(12.5%)
Breast cancer subtypes
 HR+/HER2−11(22.4%)4(13.8%)1(12.5%)
 HR+/HER2+12(24.5%)3(10.3%)0
 HR−/HER2+3(6.1%)1(3.4%)0
 TNBC19(38.8%)5(17.2%)0
Survival without DM43(87.8%)9(31.0%)2(25.0%)
Breast cancer subtypes
 HR+/HER2−11(22.4%)4(13.8%)1(12.5%)
 HR+/HER2+12(24.5%)2(6.9%)1(12.5%)
 HR−/HER2+2(4.1%)00
 TNBC18(36.7%)3(10.3%)0
  1. LR, local recurrence; DM, distance metastases.